Identification of ZG16B as a prognostic biomarker in breast cancer

Zymogen granule protein 16B (ZG16B) has been identified in various cancers, while so far the association between ZG16B and breast cancer hasn’t been explored. Our aim is to confirm whether it can serve as a prognostic biomarker in breast cancer. In this study, Oncomine, Cancer Cell Line Encyclopedia...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Haotian, Shi, Chunying, Liu, Xinyu, Liang, Chen, Yang, Chaochao, Wan, Xueqi, Li, Ling, Liu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718615/
https://www.ncbi.nlm.nih.gov/pubmed/33336077
http://dx.doi.org/10.1515/med-2021-0004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718615/
https://www.ncbi.nlm.nih.gov/pubmed/33336077
http://dx.doi.org/10.1515/med-2021-0004

Ejemplares similares